These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 16896148

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Persistent shedding of West Nile virus in urine of experimentally infected hamsters.
    Tonry JH, Xiao SY, Siirin M, Chen H, da Rosa AP, Tesh RB.
    Am J Trop Med Hyg; 2005 Mar; 72(3):320-4. PubMed ID: 15772329
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Yellow fever 17-D vaccine is neurotropic and produces encephalitis in immunosuppressed hamsters.
    Mateo RI, Xiao SY, Travassos da Rosa AP, Lei H, Guzman H, Lu L, Tesh RB.
    Am J Trop Med Hyg; 2007 Nov; 77(5):919-24. PubMed ID: 17984354
    [Abstract] [Full Text] [Related]

  • 7. In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection.
    Rios M, Daniel S, Dayton AI, Wood O, Hewlett IK, Epstein JS, Caglioti S, Stramer SL.
    J Infect Dis; 2008 Nov 01; 198(9):1300-8. PubMed ID: 18771407
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fatal West Nile virus encephalitis in a renal transplant recipient.
    Cushing MM, Brat DJ, Mosunjac MI, Hennigar RA, Jernigan DB, Lanciotti R, Petersen LR, Goldsmith C, Rollin PE, Shieh WJ, Guarner J, Zaki SR.
    Am J Clin Pathol; 2004 Jan 01; 121(1):26-31. PubMed ID: 14750237
    [Abstract] [Full Text] [Related]

  • 10. Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model.
    Morrey JD, Siddharthan V, Olsen AL, Wang H, Julander JG, Hall JO, Li H, Nordstrom JL, Koenig S, Johnson S, Diamond MS.
    Antimicrob Agents Chemother; 2007 Jul 01; 51(7):2396-402. PubMed ID: 17452485
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L, Bowen R, Karaca K, Murray M, Jagannatha S, Echols B, Nordgren R, Minke JM.
    Vet Ther; 2006 Jul 01; 7(3):249-56. PubMed ID: 17039448
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experimental infections with West Nile virus.
    Bowen RA, Nemeth NM.
    Curr Opin Infect Dis; 2007 Jun 01; 20(3):293-7. PubMed ID: 17471040
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. West Nile virus neuroinvasive disease.
    Davis LE, DeBiasi R, Goade DE, Haaland KY, Harrington JA, Harnar JB, Pergam SA, King MK, DeMasters BK, Tyler KL.
    Ann Neurol; 2006 Sep 01; 60(3):286-300. PubMed ID: 16983682
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.
    Martina BE, Koraka P, van den Doel P, Rimmelzwaan GF, Haagmans BL, Osterhaus AD.
    Virus Res; 2008 Jul 01; 135(1):64-71. PubMed ID: 18405996
    [Abstract] [Full Text] [Related]

  • 20. Antiviral peptides targeting the west nile virus envelope protein.
    Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.
    J Virol; 2007 Feb 01; 81(4):2047-55. PubMed ID: 17151121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.